Zymeworks (ZYME) Net Cash Flow (2021 - 2026)

Zymeworks (ZYME) has 6 years of Net Cash Flow data on file, last reported at $203.0 million in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow rose 1911.96% year-over-year to $203.0 million; the trailing twelve-month figure through Mar 2026 stood at $168.0 million (up 533.23% YoY), and the FY2025 full-year result was -$24.9 million, up 72.86% from the prior year.
• Net Cash Flow grew to $203.0 million in Q1 2026, from -$23.6 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $304.9 million in Q4 2022 to a low of -$219.7 million in Q1 2023.
• A 5-year average of $2.4 million and a median of -$33.5 million in 2025 frame the typical range for Net Cash Flow.
• Across the five-year window, Net Cash Flow sank 397.78% in 2023 and jumped 1911.96% in 2026, its largest moves.
• Tracing ZYME's Net Cash Flow over 5 years: stood at $304.9 million in 2022, then plunged by 79.26% to $63.2 million in 2023, then sank by 189.15% to -$56.4 million in 2024, then jumped by 58.07% to -$23.6 million in 2025, then soared by 959.08% to $203.0 million in 2026.
• Business Quant data shows ZYME's Net Cash Flow at $203.0 million in Q1 2026, -$23.6 million in Q4 2025, and -$33.5 million in Q3 2025.